The FDA has announced plans to take action against manufacturers and distributors of Natural Desiccated Thyroid (NDT) medications such as Armour Thyroid, NP Thyroid, Nature-Throid, and Natural Thyroid. These treatments have been safely used for over a century and are often the only effective option for patients who do not respond to synthetic thyroid hormones like Synthroid or Levothyroxine.

By reclassifying NDT as an “unapproved” or “biologic” drug, the FDA is creating barriers that could remove it from the market entirely, forcing patients into synthetic-only options. This decision not only threatens treatment choice but also undermines the doctor-patient relationship by allowing bureaucratic interference in personal medical care.

While the FDA has announced a temporary allowance for NDT production over the next 12 months, the long-term risk remains. Patients and providers must act now to ensure ongoing access to this critical medication.

Sign this petition to urge the FDA to protect access to NDT, maintain treatment options for those who rely on it, and safeguard medical freedom for all.